Access cutting-edge myelofibrosis treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access myelofibrosis specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myelofibrosis treatment provided free
This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or high-risk primary or secondary MF.
Sponsor: Sumitomo Pharma America, Inc.
Check if you qualify for this myelofibrosis clinical trial in Denver, CO
If you're searching for myelofibrosis treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myelofibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.